Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome.

Stem Cell Res

Stanford Cardiovascular Institute, United States; Depart of Medicine, Division of Cardiovascular Medicine, United States; Department of Radiology, Stanford University School of Medicine, United States. Electronic address:

Published: July 2021

Congenital long QT syndrome type 2 (LQT2) results from KCNH2 mutations that cause loss of Kv11.1 channel function which can lead to arrhythmias, syncope, and sudden death. Here, we generated three human-induced pluripotent stem cell (iPSC) lines from peripheral blood mononuclear cells (PBMCs) of two LQT2 patients carrying pathogenic variants (c.1714G > A and c.2960del) and one LQT2 patient carrying a variant of uncertain significance (c.1870A > T) in KCNH2. All lines show typical iPSC morphology, high expression of pluripotent markers, normal karyotype, and differentiate into three germ layers in vitro. These lines are valuable resources for studying the pathological mechanisms of LQTS caused by caused by KCNH2 mutations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10875632PMC
http://dx.doi.org/10.1016/j.scr.2021.102402DOI Listing

Publication Analysis

Top Keywords

pluripotent stem
8
stem cell
8
kcnh2 mutations
8
generation three
4
three heterozygous
4
kcnh2
4
heterozygous kcnh2
4
kcnh2 mutation-carrying
4
mutation-carrying human
4
human induced
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!